Molecular Diagnostics
Total Trials
12
As Lead Sponsor
9
As Collaborator
3
Total Enrollment
15,799
NCT00696345
Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2005
Completion: Feb 28, 2007
NCT00855348
PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
Start: Jun 30, 2008
Completion: Apr 30, 2010
NCT01329718
Specimens for Septin 9 Performance
Phase: Early Phase 1
Start: May 31, 2011
Completion: Dec 31, 2012
NCT01653002
Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging
Role: Collaborator
Start: Feb 29, 2012
Completion: Jun 30, 2014
NCT01580540
Head to Head Study Epi proColon and FIT
Start: Mar 31, 2012
Completion: Nov 30, 2012
NCT01574677
Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test
Start: Jun 30, 2012
Completion: Not specified
NCT02198092
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
Start: Jul 31, 2014
Completion: Aug 31, 2019
NCT02251782
Adherence to Minimally Invasive Testing
Start: Oct 31, 2014
Completion: Jun 30, 2015
NCT03218423
Longitudinal Performance of Epi proColon
Start: Aug 18, 2017
Completion: Jan 31, 2024
NCT03311152
Circulating Cell-free DNA-based Epigenetic Biomarker MSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis
Start: Feb 12, 2018
Completion: Oct 17, 2024
NCT03804593
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Start: Dec 17, 2018
Completion: Oct 31, 2019
NCT04027790
Plasma-based Colorectal Cancer Screening Research & Development
Start: May 3, 2019
Completion: Mar 31, 2020
Loading map...